{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T04:35:11Z","timestamp":1792902911830,"version":"4.5.0"},"reference-count":173,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"The Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-001927"],"award-info":[{"award-number":["INV-001927"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"The Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-068808"],"award-info":[{"award-number":["INV-068808"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,8,15]]},"abstract":"<jats:p>\n                    Artemisinin partial resistance (ART-R) in\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    is a major challenge to malaria control globally. Over the last two decades, ART-R has spread widely across Southeast Asia, undermining public health strategies and hindering elimination. As of 2024, ART-R has now emerged in East Africa, with the potential to dramatically impact current efforts to control malaria in the region. Mitigating its spread requires detailed genomic surveillance of point mutations in the\n                    <jats:italic>kelch13<\/jats:italic>\n                    gene, the primary known determinant of artemisinin resistance. Although extensive surveillance data on these markers is available, it is distributed across many literature studies and open databases. In this review, we aggregate spatiotemporal data for 112,933\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    samples collected between 1980 and 2023 into a single resource, providing the most comprehensive overview of\n                    <jats:italic>kelch13<\/jats:italic>\n                    markers to date. We outline the history and current status of these mutations globally, with particular focus on their emergence in Southeast Asia and East\/Northeast Africa. Concerningly, we find the recent increases in ART-R in Africa mirror patterns observed in Southeast Asia 10\u201315 years ago. We examine factors that may influence its spread, including fitness costs, treatment strategies, and local epidemiological dynamics, before discussing potential scenarios for how resistance may spread in Africa in coming years. This review provides a comprehensive account of how the situation of ART-R has unfolded globally so far, highlighting insights for researchers and public health bodies which aim to reduce its negative effects.\n                  <\/jats:p>","DOI":"10.7554\/elife.105544","type":"journal-article","created":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T08:15:11Z","timestamp":1755245711000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.105544","source":"Crossref","is-referenced-by-count":35,"title":["Understanding the global rise of artemisinin resistance: Insights from over 100,000 Plasmodium falciparum samples"],"prefix":"10.7554","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7446-3428","authenticated-orcid":true,"given":"Andrew J","family":"Balmer","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cy4wa09","id-type":"ROR","asserted-by":"publisher"}],"name":"Genomic Surveillance Unit, Wellcome Sanger Institute","place":["Hinxton, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7110-7874","authenticated-orcid":true,"given":"Nina FD","family":"White","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cy4wa09","id-type":"ROR","asserted-by":"publisher"}],"name":"Genomic Surveillance Unit, Wellcome Sanger Institute","place":["Hinxton, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2200-0928","authenticated-orcid":true,"given":"Eyy\u00fcb S","family":"\u00dcnl\u00fc","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cy4wa09","id-type":"ROR","asserted-by":"publisher"}],"name":"Genomic Surveillance Unit, Wellcome Sanger Institute","place":["Hinxton, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"data-curation","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2103-5184","authenticated-orcid":true,"given":"Chiyun","family":"Lee","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cy4wa09","id-type":"ROR","asserted-by":"publisher"}],"name":"Genomic Surveillance Unit, Wellcome Sanger Institute","place":["Hinxton, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7386-3566","authenticated-orcid":true,"given":"Richard D","family":"Pearson","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cy4wa09","id-type":"ROR","asserted-by":"publisher"}],"name":"Genomic Surveillance Unit, Wellcome Sanger Institute","place":["Hinxton, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0595-7333","authenticated-orcid":true,"given":"Jacob","family":"Almagro-Garcia","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cy4wa09","id-type":"ROR","asserted-by":"publisher"}],"name":"Genomic Surveillance Unit, Wellcome Sanger Institute","place":["Hinxton, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0887-5993","authenticated-orcid":true,"given":"Cristina","family":"Ariani","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/05cy4wa09","id-type":"ROR","asserted-by":"publisher"}],"name":"Genomic Surveillance Unit, Wellcome Sanger Institute","place":["Hinxton, United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"},{"role":"conceptualization","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"resources","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"writing-review-editing","vocabulary":"credit"}]}],"member":"4374","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.18681.1","type":"journal-article","article-title":"Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples","volume":"8","author":"Abdel Hamid","year":"2023","journal-title":"Wellcome Open Research"},{"key":"bib2","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04194-7","type":"journal-article","article-title":"The prevalence of symptomatic and asymptomatic malaria and its associated factors in Debre Elias district communities, Northwest Ethiopia","volume":"21","author":"Abebaw","year":"2022","journal-title":"Malaria Journal"},{"key":"bib3","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-03660-y","type":"journal-article","article-title":"Genomic analysis reveals independent evolution of Plasmodium falciparum populations in Ethiopia","volume":"20","author":"Abera","year":"2021","journal-title":"Malaria Journal"},{"key":"bib4","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-022-04421-1","type":"journal-article","article-title":"Asymptomatic malaria infection, associated factors and accuracy of diagnostic tests in a historically high transmission setting in Northern Uganda","volume":"21","author":"Agaba","year":"2022","journal-title":"Malaria Journal"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1126\/science.aav5427","type":"journal-article","article-title":"Major subpopulations of Plasmodium falciparum in sub-Saharan Africa","volume":"365","author":"Amambua-Ngwa","year":"2019","journal-title":"Science"},{"key":"bib6","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1473-3099(18)30068-9","type":"journal-article","article-title":"Origins of the current outbreak of multidrug-resistant malaria in southeast Asia: a retrospective genetic study","volume":"18","author":"Amato","year":"2018","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0316479","type":"journal-article","article-title":"Polymorphisms in Pfkelch13 domains before and after the introduction of artemisinin-based combination therapy in Southwest Nigeria","volume":"20","author":"Amusan","year":"2025","journal-title":"PLOS ONE"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/molbev\/msw228","type":"journal-article","article-title":"Population parameters underlying an ongoing soft sweep in Southeast Asian malaria parasites","volume":"34","author":"Anderson","year":"2017","journal-title":"Molecular Biology and Evolution"},{"key":"bib9","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-422","type":"journal-article","article-title":"Policy options for deploying anti-malarial drugs in endemic countries: a population genetics approach","volume":"11","author":"Antao","year":"2012","journal-title":"Malaria Journal"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature12876","type":"journal-article","article-title":"A molecular marker of artemisinin-resistant Plasmodium falciparum malaria","volume":"505","author":"Ariey","year":"2014","journal-title":"Nature"},{"key":"bib11","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1314981","type":"journal-article","article-title":"Spread of artemisinin resistance in Plasmodium falciparum malaria","volume":"371","author":"Ashley","year":"2014","journal-title":"The New England Journal of Medicine"},{"key":"bib12","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-04848-8","type":"journal-article","article-title":"Emergence of Plasmodium falciparum strains with artemisinin partial resistance in East Africa and the Horn of Africa: is there a need to panic?","volume":"23","author":"Assefa","year":"2024","journal-title":"Malaria Journal"},{"key":"bib13","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01818-18","type":"journal-article","article-title":"Changing molecular markers of antimalarial drug sensitivity across Uganda","volume":"63","author":"Asua","year":"2019","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1073\/pnas.1615875114","type":"journal-article","article-title":"Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort","volume":"114","author":"Ataide","year":"2017","journal-title":"PNAS"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","type":"journal-article","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"The New England Journal of Medicine"},{"key":"bib16","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad3292","type":"journal-article","article-title":"Multidrug evolutionary strategies to reverse antibiotic resistance","volume":"351","author":"Baym","year":"2016","journal-title":"Science"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"2998","DOI":"10.1002\/med.21848","type":"journal-article","article-title":"The newly discovered role of endocytosis in artemisinin resistance","volume":"41","author":"Behrens","year":"2021","journal-title":"Medicinal Research Reviews"},{"key":"bib18","doi-asserted-by":"publisher","DOI":"10.1101\/2022.05.13.491767","type":"preprint","article-title":"Impact of different mutations on kelch13 protein levels, ART resistance and fitness cost in Plasmodium falciparum parasites","volume-title":"bioRxiv","author":"Behrens","year":"2023"},{"key":"bib19","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.01981-23","type":"journal-article","article-title":"Impact of different mutations on Kelch13 protein levels, ART resistance, and fitness cost in Plasmodium falciparum parasites","volume":"15","author":"Behrens","year":"2024","journal-title":"mBio"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"e418","DOI":"10.1016\/S2214-109X(17)30076-1","type":"journal-article","article-title":"Population coverage of artemisinin-based combination treatment in children younger than 5 years with fever and Plasmodium falciparum infection in Africa, 2003-2015: a modelling study using data from national surveys","volume":"5","author":"Bennett","year":"2017","journal-title":"The Lancet. Global Health"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/jeea\/jvab053","type":"journal-article","article-title":"Can good products drive out bad? a randomized intervention in the antimalarial medicine market in Uganda","volume":"20","author":"Bj\u00f6rkman Nyqvist","year":"2022","journal-title":"Journal of the European Economic Association"},{"key":"bib22","doi-asserted-by":"publisher","first-page":"14216","DOI":"10.1073\/pnas.0804628105","type":"journal-article","article-title":"Benefits of using multiple first-line therapies against malaria","volume":"105","author":"Boni","year":"2008","journal-title":"PNAS"},{"key":"bib23","doi-asserted-by":"publisher","DOI":"10.3389\/fepid.2022.1041896","type":"journal-article","article-title":"Breaking the cycle of malaria treatment failure","volume":"2","author":"Boni","year":"2022","journal-title":"Frontiers in Epidemiology"},{"key":"bib24","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-2128-x","type":"journal-article","article-title":"Plasmodium falciparum kelch 13 mutations and treatment response in patients in Hpa-Pun District, Northern Kayin state, Myanmar","volume":"16","author":"Bonnington","year":"2017","journal-title":"Malaria Journal"},{"key":"bib25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-30593-5","type":"journal-article","article-title":"Fitness loss under amino acid starvation in Artemisinin-resistant Plasmodium falciparum isolates from Cambodia","volume":"8","author":"Bunditvorapoom","year":"2018","journal-title":"Scientific Reports"},{"key":"bib26","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.2005712","type":"journal-article","article-title":"Within-host competition can delay evolution of drug resistance in malaria","volume":"16","author":"Bushman","year":"2018","journal-title":"PLOS Biology"},{"key":"bib27","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19063544","type":"journal-article","article-title":"Asymptomatic malaria infections in the time of COVID-19 pandemic: experience from the central African republic","volume":"19","author":"Bylicka-Szczepanowska","year":"2022","journal-title":"International Journal of Environmental Research and Public Health"},{"key":"bib28","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-017-1204-4","type":"journal-article","article-title":"Longitudinal genomic surveillance of Plasmodium falciparum malaria parasites reveals complex genomic architecture of emerging artemisinin resistance","volume":"18","author":"Cerqueira","year":"2017","journal-title":"Genome Biology"},{"key":"bib29","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/S1473-3099(21)00748-9","type":"journal-article","article-title":"Triple artemisinin-based combination therapies for malaria: a timely solution to counter antimalarial drug resistance","volume":"22","author":"Chen","year":"2022","journal-title":"The Lancet Infectious Diseases"},{"key":"bib30","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7054","type":"journal-article","article-title":"Human-to-mosquito transmission efficiency increases as malaria is controlled","volume":"6","author":"Churcher","year":"2015","journal-title":"Nature Communications"},{"key":"bib31","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-122","type":"journal-article","article-title":"Malaria resurgence: a systematic review and assessment of its causes","volume":"11","author":"Cohen","year":"2012","journal-title":"Malaria Journal"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"e338","DOI":"10.1016\/S1473-3099(19)30261-0","type":"journal-article","article-title":"Antimalarial drug resistance in Africa: the calm before the storm?","volume":"19","author":"Conrad","year":"2019","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2211803","type":"journal-article","article-title":"Evolution of partial resistance to Artemisinins in malaria parasites in Uganda","volume":"389","author":"Conrad","year":"2023","journal-title":"The New England Journal of Medicine"},{"key":"bib34","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.943445","type":"journal-article","article-title":"Genome-wide SNP analysis of Plasmodium falciparum shows differentiation at drug-resistance-associated loci among malaria transmission settings in southern Mali","volume":"13","author":"Coulibaly","year":"2022","journal-title":"Frontiers in Genetics"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0140-6736(23)02511-4","type":"journal-article","article-title":"Safety and efficacy of malaria vaccine candidate R21\/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial","volume":"403","author":"Datoo","year":"2024","journal-title":"The Lancet"},{"key":"bib36","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-023-04666-4","type":"journal-article","article-title":"Strategies for deploying triple artemisinin-based combination therapy in the Greater Mekong Subregion","volume":"22","author":"de Haan","year":"2023","journal-title":"Malaria Journal"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.4269\/ajtmh.17-0505","type":"journal-article","article-title":"Polymorphisms in the K13 Gene in Plasmodium falciparum from different malaria transmission areas of Kenya","volume":"98","author":"de Laurent","year":"2018","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"12799","DOI":"10.1073\/pnas.1812317115","type":"journal-article","article-title":"Mutations in Plasmodium falciparum actin-binding protein coronin confer reduced artemisinin susceptibility","volume":"115","author":"Demas","year":"2018","journal-title":"PNAS"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1126\/science.adp5137","type":"journal-article","article-title":"Artemisinin-resistant malaria in Africa demands urgent action","volume":"385","author":"Dhorda","year":"2024","journal-title":"Science"},{"key":"bib40","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01949-20","type":"journal-article","article-title":"Continued low efficacy of artemether-lumefantrine in Angola in 2019","volume":"65","author":"Dimbu","year":"2021","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"bib41","doi-asserted-by":"publisher","DOI":"10.1128\/aac.01525-23","type":"journal-article","article-title":"Therapeutic response to four artemisinin-based combination therapies in Angola, 2021","volume":"68","author":"Dimbu","year":"2024","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1056\/NEJMoa0808859","type":"journal-article","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1128\/CMR.00025-08","type":"journal-article","article-title":"Acquired immunity to malaria","volume":"22","author":"Doolan","year":"2009","journal-title":"Clinical Microbiology Reviews"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.pt.2021.04.006","type":"journal-article","article-title":"Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials","volume":"37","author":"Duffey","year":"2021","journal-title":"Trends in Parasitology"},{"key":"bib45","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-04021-5","type":"journal-article","article-title":"Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda","volume":"20","author":"Ebong","year":"2021","journal-title":"Malaria Journal"},{"key":"bib46","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jpha.2020.07.005","type":"journal-article","article-title":"Protecting future antimalarials from the trap of resistance: Lessons from artemisinin-based combination therapy (ACT) failures","volume":"11","author":"Erhunse","year":"2021","journal-title":"Journal of Pharmaceutical Analysis"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1038\/s41564-023-01461-4","type":"journal-article","article-title":"Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia","volume":"8","author":"Fola","year":"2023","journal-title":"Nature Microbiology"},{"key":"bib48","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-03585-6","type":"journal-article","article-title":"Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017-2018","volume":"20","author":"Gansan\u00e9","year":"2021","journal-title":"Malaria Journal"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1124\/pr.57.1.4","type":"journal-article","article-title":"Mechanisms of resistance of malaria parasites to antifolates","volume":"57","author":"Gregson","year":"2005","journal-title":"Pharmacological Reviews"},{"key":"bib50","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.1003949","type":"journal-article","article-title":"Criteria for selecting sentinel unit locations in a surveillance system for vector-borne disease: A decision tool","volume":"10","author":"Guillot","year":"2022","journal-title":"Frontiers in Public Health"},{"key":"bib51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185315","type":"journal-article","article-title":"Economic burden of malaria and predictors of cost variability to rural households in south-central Ethiopia","volume":"12","author":"Hailu","year":"2017","journal-title":"PLOS ONE"},{"key":"bib52","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1016\/S1473-3099(19)30392-5","type":"journal-article","article-title":"Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study","volume":"19","author":"Hamilton","year":"2019","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/j.pt.2023.09.014","type":"journal-article","article-title":"Nanopore sequencing for malaria molecular surveillance: opportunities and challenges","volume":"39","author":"Hamilton","year":"2023","journal-title":"Trends in Parasitology"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/bcp.14474","type":"journal-article","article-title":"Advances and roadblocks in the treatment of malaria","volume":"88","author":"Hanboonkunupakarn","year":"2022","journal-title":"British Journal of Clinical Pharmacology"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.4269\/ajtmh.19-0379","type":"journal-article","article-title":"Origin and spread of evolving artemisinin-resistant Plasmodium falciparum malarial parasites in Southeast Asia","volume":"101","author":"Hassett","year":"2019","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"bib56","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.90888","type":"journal-article","article-title":"Antigenic strain diversity predicts different biogeographic patterns of maintenance and decline of antimalarial drug resistance","volume":"12","author":"He","year":"2024","journal-title":"eLife"},{"key":"bib57","doi-asserted-by":"publisher","first-page":"6935","DOI":"10.1021\/acs.biochem.8b00960","type":"journal-article","article-title":"Dihydroartemisinin-Ferriprotoporphyrin IX adduct abundance in Plasmodium falciparum malarial parasites and the relationship to emerging artemisinin resistance","volume":"57","author":"Heller","year":"2018","journal-title":"Biochemistry"},{"key":"bib58","doi-asserted-by":"publisher","first-page":"6927","DOI":"10.1021\/acs.biochem.8b00959","type":"journal-article","article-title":"Quantification of free Ferriprotoporphyrin IX Heme and Hemozoin for Artemisinin sensitive versus delayed clearance phenotype Plasmodium falciparum malarial parasites","volume":"57","author":"Heller","year":"2018","journal-title":"Biochemistry"},{"key":"bib59","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1007279","type":"journal-article","article-title":"Identity-by-descent analyses for measuring population dynamics and selection in recombining pathogens","volume":"14","author":"Henden","year":"2018","journal-title":"PLOS Genetics"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1093\/infdis\/jiu358","type":"journal-article","article-title":"Directional selection at the pfmdr1, pfcrt, pfubp1, and pfap2mu loci of Plasmodium falciparum in Kenyan children treated with ACT","volume":"210","author":"Henriques","year":"2014","journal-title":"The Journal of Infectious Diseases"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"718","DOI":"10.3201\/eid2404.170141","type":"journal-article","article-title":"Artemisinin-resistant Plasmodium falciparum with high survival rates, Uganda, 2014-2016","volume":"24","author":"Ikeda","year":"2018","journal-title":"Emerging Infectious Diseases"},{"key":"bib62","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S1473-3099(17)30048-8","type":"journal-article","article-title":"The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study","volume":"17","author":"Imwong","year":"2017","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib63","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/S1473-3099(20)30228-0","type":"journal-article","article-title":"Molecular epidemiology of resistance to antimalarial drugs in the greater Mekong subregion: an observational study","volume":"20","author":"Imwong","year":"2020","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.4269\/ajtmh.20-0852","type":"journal-article","article-title":"Therapeutic efficacy of artemether-lumefantrine for uncomplicated falciparum malaria in Northern Zambia","volume":"103","author":"Ippolito","year":"2020","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"bib65","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-019-2853-4","type":"journal-article","article-title":"Deployment and utilization of next-generation sequencing of Plasmodium falciparum to guide anti-malarial drug policy decisions in sub-Saharan Africa: opportunities and challenges","volume":"18","author":"Ishengoma","year":"2019","journal-title":"Malaria Journal"},{"key":"bib66","doi-asserted-by":"publisher","DOI":"10.1101\/2024.01.31.24301954","type":"preprint","article-title":"Evidence of artemisinin partial resistance in North-Western Tanzania: clinical and drug resistance markers study","volume-title":"medRxiv","author":"Ishengoma","year":"2024"},{"key":"bib67","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.62997","type":"journal-article","article-title":"Genetic surveillance in the Greater Mekong subregion and South Asia to support malaria control and elimination","volume":"10","author":"Jacob","year":"2021","journal-title":"eLife"},{"key":"bib68","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3347\/PHD.22140","type":"journal-article","article-title":"Monitoring antimalarial drug-resistance markers in Somalia","volume":"61","author":"Jalei","year":"2023","journal-title":"Parasites, Hosts and Diseases"},{"key":"bib69","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-023-04812-y","type":"journal-article","article-title":"Molecular surveillance of Kelch 13 polymorphisms in Plasmodium falciparum isolates from Kenya and Ethiopia","volume":"23","author":"Jeang","year":"2024","journal-title":"Malaria Journal"},{"key":"bib70","doi-asserted-by":"publisher","first-page":"e184","DOI":"10.1016\/S2666-5247(21)00249-4","type":"journal-article","article-title":"Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis","volume":"3","author":"Kagoro","year":"2022","journal-title":"The Lancet. Microbe"},{"key":"bib71","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/S1473-3099(20)30493-X","type":"journal-article","article-title":"Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin: a systematic review","volume":"21","author":"Kayiba","year":"2021","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib72","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02141-17","type":"journal-article","article-title":"Emergence and spread of kelch13 mutations associated with artemisinin resistance in Plasmodium falciparum parasites in 12 Thai Provinces from 2007 to 2016","volume":"62","author":"Kobasa","year":"2018","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"bib73","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-04844-y","type":"journal-article","article-title":"Triple artemisinin-based combination therapy (TACT): advancing malaria control and eradication efforts","volume":"23","author":"Kokori","year":"2024","journal-title":"Malaria Journal"},{"key":"bib74","doi-asserted-by":"publisher","DOI":"10.1101\/2024.07.16.603783","type":"preprint","article-title":"Pf-HaploAtlas: an interactive web app for spatiotemporal analysis of P. falciparum Genes.","volume-title":"bioRxiv","author":"Lee","year":"2024"},{"key":"bib75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45547-x","type":"journal-article","article-title":"Assessing emergence risk of double-resistant and triple-resistant genotypes of Plasmodium falciparum","volume":"15","author":"Li","year":"2024","journal-title":"Nature Communications"},{"key":"bib76","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-13-452","type":"journal-article","article-title":"Artemisinin resistance--modelling the potential human and economic costs","volume":"13","author":"Lubell","year":"2014","journal-title":"Malaria Journal"},{"key":"bib77","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.757844","type":"journal-article","article-title":"Potential opportunities and challenges of deploying next generation sequencing and CRISPR-Cas systems to support diagnostics and surveillance towards malaria control and elimination in Africa","volume":"12","author":"Lyimo","year":"2022","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"bib78","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-024-04851-z","type":"journal-article","article-title":"Progress towards malaria elimination in the Greater Mekong Subregion: perspectives from the World Health Organization","volume":"23","author":"Manzoni","year":"2024","journal-title":"Malaria Journal"},{"key":"bib79","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.51015","type":"journal-article","article-title":"Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance","volume":"9","author":"Mathieu","year":"2020","journal-title":"eLife"},{"key":"bib80","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.pt.2023.08.007","type":"journal-article","article-title":"Sampling for malaria molecular surveillance","volume":"39","author":"Mayor","year":"2023","journal-title":"Trends in Parasitology"},{"key":"bib81","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.03.24302209","type":"preprint","article-title":"Selection of Artemisinin Partial Resistance Kelch13 Mutations in Uganda in 2016-22 Was at a Rate Comparable to That Seen Previously in South-East Asia","volume-title":"medRxiv","author":"Meier-Scherling","year":"2024"},{"key":"bib82","doi-asserted-by":"publisher","DOI":"10.3389\/fepid.2022.939291","type":"journal-article","article-title":"Genomic approaches for monitoring transmission dynamics of malaria: A case for malaria molecular surveillance in Sub-Saharan Africa","volume":"2","author":"Mensah","year":"2022","journal-title":"Frontiers in Epidemiology"},{"key":"bib83","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.chom.2021.11.002","type":"journal-article","article-title":"The parasitophorous vacuole nutrient channel is critical for drug access in malaria parasites and modulates the artemisinin resistance fitness cost","volume":"29","author":"Mes\u00e9n-Ram\u00edrez","year":"2021","journal-title":"Cell Host & Microbe"},{"key":"bib84","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1056\/NEJMoa2210956","type":"journal-article","article-title":"Increasing prevalence of artemisinin-resistant HRP2-negative malaria in eritrea","volume":"389","author":"Mihreteab","year":"2023","journal-title":"New England Journal of Medicine"},{"key":"bib85","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ng.2624","type":"journal-article","article-title":"Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia","volume":"45","author":"Miotto","year":"2013","journal-title":"Nature Genetics"},{"key":"bib86","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/ng.3189","type":"journal-article","article-title":"Genetic architecture of artemisinin-resistant Plasmodium falciparum","volume":"47","author":"Miotto","year":"2015","journal-title":"Nature Genetics"},{"key":"bib87","doi-asserted-by":"publisher","DOI":"10.1101\/2024.01.20.576496","type":"preprint","article-title":"A Complex Plasmodium falciparum Cryptotype Circulating at Low Frequency across the African Continent","volume-title":"bioRxiv","author":"Miotto","year":"2024"},{"key":"bib88","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1080\/20477724.2017.1331875","type":"journal-article","article-title":"Clinical and molecular monitoring of    Plasmodium falciparum    resistance to antimalarial drug (artesunate+sulphadoxine-pyrimethamine) in two highly malarious district of Madhya Pradesh, Central India from 2012\u20132014","volume":"111","author":"Mishra","year":"2017","journal-title":"Pathogens and Global Health"},{"key":"bib89","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.parint.2009.04.004","type":"journal-article","article-title":"Spread and evolution of Plasmodium falciparum drug resistance","volume":"58","author":"Mita","year":"2009","journal-title":"Parasitology International"},{"key":"bib90","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03165-0","type":"journal-article","article-title":"Assessment of Plasmodium falciparum drug resistance molecular markers from the Blue Nile State, Southeast Sudan","volume":"19","author":"Mohamed","year":"2020","journal-title":"Malaria Journal"},{"key":"bib91","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1126\/science.1260403","type":"journal-article","article-title":"Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance","volume":"347","author":"Mok","year":"2015","journal-title":"Science"},{"key":"bib92","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.4269\/ajtmh.21-0214","type":"journal-article","article-title":"Therapeutic efficacy of artemisinin-based combination therapies in democratic republic of the congo and investigation of molecular markers of antimalarial resistance","volume":"105","author":"Moriarty","year":"2021","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"bib93","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-1845-5","type":"journal-article","article-title":"Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia","volume":"16","author":"Mukherjee","year":"2017","journal-title":"Malaria Journal"},{"key":"bib94","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/S0140-6736(12)60034-8","type":"journal-article","article-title":"Global malaria mortality between 1980 and 2010: a systematic analysis","volume":"379","author":"Murray","year":"2012","journal-title":"The Lancet"},{"key":"bib95","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233478","type":"journal-article","article-title":"Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana","volume":"15","author":"Myers-Hansen","year":"2020","journal-title":"PLOS ONE"},{"key":"bib96","doi-asserted-by":"publisher","first-page":"00605","DOI":"10.1128\/AAC.00605-18","type":"journal-article","article-title":"Fitness costs and the rapid spread of kelch13-C580Y substitutions conferring artemisinin resistance","volume":"62","author":"Nair","year":"2018","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"bib97","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54915-6","type":"journal-article","article-title":"Population genomics and transcriptomics of Plasmodium falciparum in Cambodia and Vietnam uncover key components of the artemisinin resistance genetic background","volume":"15","author":"Nayak","year":"2024","journal-title":"Nature Communications"},{"key":"bib98","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.ijpddr.2021.07.004","type":"journal-article","article-title":"Genetic surveillance for monitoring the impact of drug use on Plasmodium falciparum populations","volume":"17","author":"Ndiaye","year":"2021","journal-title":"International Journal for Parasitology. Drugs and Drug Resistance"},{"key":"bib99","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1038\/s41576-021-00349-5","type":"journal-article","article-title":"Advances and opportunities in malaria population genomics","volume":"22","author":"Neafsey","year":"2021","journal-title":"Nature Reviews. Genetics"},{"key":"bib100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0030197","type":"journal-article","article-title":"Manslaughter by fake artesunate in Asia--will Africa be next?","volume":"3","author":"Newton","year":"2006","journal-title":"PLOS Medicine"},{"key":"bib101","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(15)00162-X","type":"journal-article","article-title":"Optimum population-level use of artemisinin combination therapies: a modelling study","volume":"3","author":"Nguyen","year":"2015","journal-title":"The Lancet. Global Health"},{"key":"bib102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39914-3","type":"journal-article","article-title":"Preventing antimalarial drug resistance with triple artemisinin-based combination therapies","volume":"14","author":"Nguyen","year":"2023","journal-title":"Nature Communications"},{"key":"bib103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgph.0002200","type":"journal-article","article-title":"Antimalarial mass drug administration in large populations and the evolution of drug resistance","volume":"3","author":"Nguyen","year":"2023","journal-title":"PLOS Global Public Health"},{"key":"bib104","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMc0805011","type":"journal-article","article-title":"Evidence of artemisinin-resistant malaria in western Cambodia","volume":"359","author":"Noedl","year":"2008","journal-title":"The New England Journal of Medicine"},{"key":"bib105","doi-asserted-by":"publisher","first-page":"181","DOI":"10.4269\/ajtmh.2007.77.181","type":"journal-article","article-title":"Artemisinin-based combination treatment of falciparum malaria","volume":"77","author":"Nosten","year":"2007","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"bib106","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2185-9","type":"journal-article","article-title":"Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape","volume":"17","author":"Nsanzabana","year":"2018","journal-title":"Malaria Journal"},{"key":"bib107","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-03942-5","type":"journal-article","article-title":"Time to scale up molecular surveillance for anti-malarial drug resistance in sub-saharan Africa","volume":"20","author":"Nsanzabana","year":"2021","journal-title":"Malaria Journal"},{"key":"bib108","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.4269\/ajtmh.14-0605","type":"journal-article","article-title":"Polymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, Mali","volume":"92","author":"Ouattara","year":"2015","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"bib109","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-03987-6","type":"journal-article","article-title":"Prevalence of potential mediators of artemisinin resistance in African isolates of Plasmodium falciparum","volume":"20","author":"Owoloye","year":"2021","journal-title":"Malaria Journal"},{"key":"bib110","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.pt.2023.09.011","type":"journal-article","article-title":"The many paths to artemisinin resistance in Plasmodium falciparum","volume":"39","author":"Pandit","year":"2023","journal-title":"Trends in Parasitology"},{"key":"bib111","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1093\/gbe\/evx126","type":"journal-article","article-title":"PArtner-drug resistance and population substructuring of artemisinin-resistant Plasmodium falciparum in Cambodia","volume":"9","author":"Parobek","year":"2017","journal-title":"Genome Biology and Evolution"},{"key":"bib112","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/S1473-3099(21)00692-7","type":"journal-article","article-title":"Triple therapy with artemether-lumefantrine plus amodiaquine versus artemether-lumefantrine alone for artemisinin-resistant, uncomplicated falciparum malaria: an open-label, randomised, multicentre trial","volume":"22","author":"Peto","year":"2022","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib113","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-7-229","type":"journal-article","article-title":"Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies","volume":"7","author":"Pongtavornpinyo","year":"2008","journal-title":"Malaria Journal"},{"key":"bib114","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/14787210.2021.1962291","type":"journal-article","article-title":"Current and emerging strategies to combat antimalarial resistance","volume":"20","author":"Rasmussen","year":"2022","journal-title":"Expert Review of Anti-Infective Therapy"},{"key":"bib115","doi-asserted-by":"publisher","DOI":"10.1101\/2024.02.09.24302575","type":"preprint","article-title":"Ecological impacts of climate change will transform public health priorities for zoonotic and vector-borne disease","volume-title":"medRxiv","author":"Redding","year":"2024"},{"key":"bib116","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1146\/annurev-micro-012220-064343","type":"journal-article","article-title":"Genomic approaches to drug resistance in malaria","volume":"74","author":"Rocamora","year":"2020","journal-title":"Annual Review of Microbiology"},{"key":"bib117","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21815-y","type":"journal-article","article-title":"Malaria trends in Ethiopian highlands track the 2000 \u201cslowdown\u201d in global warming","volume":"12","author":"Rod\u00f3","year":"2021","journal-title":"Nature Communications"},{"key":"bib118","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/mmi.12349","type":"journal-article","article-title":"The interplay between drug resistance and fitness in malaria parasites","volume":"89","author":"Rosenthal","year":"2013","journal-title":"Molecular Microbiology"},{"key":"bib119","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4269\/ajtmh.18-0997","type":"journal-article","article-title":"Malaria: how are we doing and how can we do better?","volume":"100","author":"Rosenthal","year":"2019","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"bib120","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/S1473-3099(21)00168-7","type":"journal-article","article-title":"Has artemisinin resistance emerged in Africa?","volume":"21","author":"Rosenthal","year":"2021","journal-title":"The Lancet Infectious Diseases"},{"key":"bib121","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/s41579-024-01008-2","type":"journal-article","article-title":"Emergence, transmission dynamics and mechanisms of artemisinin partial resistance in malaria parasites in Africa","volume":"22","author":"Rosenthal","year":"2024","journal-title":"Nature Reviews Microbiology"},{"key":"bib122","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05652-0","type":"journal-article","article-title":"Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine","volume":"9","author":"Ross","year":"2018","journal-title":"Nature Communications"},{"key":"bib123","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(17)30635-7","type":"journal-article","article-title":"Emergence of Plasmodium falciparum triple mutant in Cambodia","volume":"17","author":"Rossi","year":"2017","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib124","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.668574","type":"journal-article","article-title":"Chloroquine and sulfadoxine-pyrimethamine resistance in sub-Saharan Africa-a review","volume":"12","author":"Roux","year":"2021","journal-title":"Frontiers in Genetics"},{"key":"bib125","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-020-03224-6","type":"journal-article","article-title":"Shifting transmission risk for malaria in Africa with climate change: a framework for planning and intervention","volume":"19","author":"Ryan","year":"2020","journal-title":"Malaria Journal"},{"key":"bib126","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-300","type":"journal-article","article-title":"Artemisinin resistance containment project in Thailand II: responses to mefloquine-artesunate combination therapy among falciparum malaria patients in provinces bordering Cambodia","volume":"11","author":"Satimai","year":"2012","journal-title":"Malaria Journal"},{"key":"bib127","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2418-y","type":"journal-article","article-title":"Implications of population-level immunity for the emergence of artemisinin-resistant malaria: a mathematical model","volume":"17","author":"Scott","year":"2018","journal-title":"Malaria Journal"},{"key":"bib128","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30700-1","type":"journal-article","article-title":"Inferring the epidemiological benefit of indoor vector control interventions against malaria from mosquito data","volume":"13","author":"Sherrard-Smith","year":"2022","journal-title":"Nature Communications"},{"key":"bib129","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-6-118","type":"journal-article","article-title":"The rationale and plan for creating a World Antimalarial Resistance Network (WARN)","volume":"6","author":"Sibley","year":"2007","journal-title":"Malaria Journal"},{"key":"bib130","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.ijpddr.2021.05.007","type":"journal-article","article-title":"Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook","volume":"16","author":"Siddiqui","year":"2021","journal-title":"International Journal for Parasitology. Drugs and Drug Resistance"},{"key":"bib131","doi-asserted-by":"publisher","DOI":"10.1186\/1756-3305-3-117","type":"journal-article","article-title":"The dominant Anopheles vectors of human malaria in Africa, Europe and the Middle East: occurrence data, distribution maps and bionomic pr\u00e9cis","volume":"3","author":"Sinka","year":"2010","journal-title":"Parasites & Vectors"},{"key":"bib132","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-1075-7","type":"journal-article","article-title":"Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa","volume":"15","author":"Slater","year":"2016","journal-title":"Malaria Journal"},{"key":"bib133","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-9-217","type":"journal-article","article-title":"Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty","volume":"9","author":"Smith","year":"2010","journal-title":"Malaria Journal"},{"key":"bib134","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.66277","type":"journal-article","article-title":"Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness","volume":"10","author":"Stokes","year":"2021","journal-title":"eLife"},{"key":"bib135","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1056\/NEJMc2117480","type":"journal-article","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"386","author":"Stokes","year":"2022","journal-title":"The New England Journal of Medicine"},{"key":"bib136","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1126\/science.1260867","type":"journal-article","article-title":"Drug resistance: K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"bib137","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00172-17","type":"journal-article","article-title":"Plasmodium falciparum K13 mutations differentially impact ozonide susceptibility and parasite fitness in vitro","volume":"8","author":"Straimer","year":"2017","journal-title":"mBio"},{"key":"bib138","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1093\/infdis\/jiab352","type":"journal-article","article-title":"High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is associated with slow parasite clearance after treatment with Artemether-Lumefantrine","volume":"225","author":"Straimer","year":"2022","journal-title":"The Journal of Infectious Diseases"},{"key":"bib139","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/infdis\/jiu491","type":"journal-article","article-title":"Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia","volume":"211","author":"Takala-Harrison","year":"2015","journal-title":"The Journal of Infectious Diseases"},{"key":"bib140","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1093\/infdis\/jiu467","type":"journal-article","article-title":"Absence of putative artemisinin resistance mutations among Plasmodium falciparum in Sub-Saharan Africa: a molecular epidemiologic study","volume":"211","author":"Taylor","year":"2015","journal-title":"The Journal of Infectious Diseases"},{"key":"bib141","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-021-03649-7","type":"journal-article","article-title":"Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations","volume":"20","author":"Tindana","year":"2021","journal-title":"Malaria Journal"},{"key":"bib142","first-page":"121","type":"book-chapter","article-title":"The intolerable burden of malaria: a new look at the numbers","volume-title":"The Intolerable Burden of Malaria: A New Look at the Numbers: Supplement to Volume 64 of the American Journal of Tropical Medicine and Hygiene","author":"Trape","year":"2001"},{"key":"bib143","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33873-x","type":"journal-article","article-title":"Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda","volume":"13","author":"Tumwebaze","year":"2022","journal-title":"Nature Communications"},{"key":"bib144","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/S1473-3099(15)70032-0","type":"journal-article","article-title":"Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker","volume":"15","author":"Tun","year":"2015","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib145","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-017-2130-3","type":"journal-article","article-title":"Towards malaria elimination in Savannakhet, Lao PDR: mathematical modelling driven strategy design","volume":"16","author":"Tun","year":"2017","journal-title":"Malaria Journal"},{"key":"bib146","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2404-4","type":"journal-article","article-title":"Effectiveness and safety of 3 and 5 day courses of artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in an area of emerging artemisinin resistance in Myanmar","volume":"17","author":"Tun","year":"2018","journal-title":"Malaria Journal"},{"key":"bib147","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","type":"journal-article","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nature Medicine"},{"key":"bib148","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","type":"journal-article","article-title":"Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study","volume":"21","author":"Uwimana","year":"2021","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib149","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","type":"journal-article","article-title":"Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial","volume":"395","author":"van der Pluijm","year":"2020","journal-title":"The Lancet"},{"key":"bib150","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.pt.2020.09.011","type":"journal-article","article-title":"Triple artemisinin-based combination therapies for malaria - a new paradigm?","volume":"37","author":"van der Pluijm","year":"2021","journal-title":"Trends in Parasitology"},{"key":"bib151","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-15779-8","type":"journal-article","article-title":"The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC","volume":"11","author":"Verity","year":"2020","journal-title":"Nature Communications"},{"key":"bib152","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-018-2454-7","type":"journal-article","article-title":"Private sector drug shops frequently dispense parenteral anti-malarials in a rural region of Western Uganda","volume":"17","author":"Wang","year":"2018","journal-title":"Malaria Journal"},{"key":"bib153","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/S1473-3099(22)00697-1","type":"journal-article","article-title":"Malaria outbreak in Laos driven by a selective sweep for Plasmodium falciparum kelch13 R539T mutants: a genetic epidemiology analysis","volume":"23","author":"Wasakul","year":"2023","journal-title":"The Lancet. Infectious Diseases"},{"key":"bib154","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1086\/322858","type":"journal-article","article-title":"Chloroquine-resistant malaria","volume":"184","author":"Wellems","year":"2001","journal-title":"The Journal of Infectious Diseases"},{"key":"bib155","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1172\/JCI21682","type":"journal-article","article-title":"Antimalarial drug resistance","volume":"113","author":"White","year":"2004","journal-title":"The Journal of Clinical Investigation"},{"key":"bib156","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-8-253","type":"journal-article","article-title":"Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance","volume":"8","author":"White","year":"2009","journal-title":"Malaria Journal"},{"key":"bib157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1008577","type":"journal-article","article-title":"Immune selection suppresses the emergence of drug resistance in malaria parasites but facilitates its spread","volume":"17","author":"Whitlock","year":"2021","journal-title":"PLOS Computational Biology"},{"key":"bib158","type":"web-resource","article-title":"Guidelines for the treatment of malaria","author":"World Health Organization","year":"2006","unstructured":"World Health Organization. 2006. Guidelines for the treatment of malaria. https:\/\/www.who.int\/publications\/i\/item\/guidelines-for-malaria [Accessed August 13, 2025]."},{"key":"bib159","type":"web-resource","article-title":"Minutes of the drug resistance and containment technical expert group","author":"World Health Organization","year":"2009","unstructured":"World Health Organization. 2009. Minutes of the drug resistance and containment technical expert group. https:\/\/www.who.int\/publications\/i\/item\/9789241597531 [Accessed October 13, 2009]."},{"key":"bib160","type":"web-resource","article-title":"Minutes of the drug resistance and containment technical expert group","author":"World Health Organization","year":"2013","unstructured":"World Health Organization. 2013. Minutes of the drug resistance and containment technical expert group. https:\/\/www.who.int\/publications\/m\/item\/minutes-of-the-drug-resistance-and-containment-technical-expert-group-june-2013 [Accessed June 27, 2013]."},{"key":"bib161","type":"web-resource","article-title":"Guidelines for the treatment of malaria","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. 2015a. Guidelines for the treatment of malaria. https:\/\/www.paho.org\/en\/node\/64471 [Accessed November 7, 2015]."},{"key":"bib162","type":"web-resource","article-title":"Strategy for malaria elimination in the greater mekong subregion","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. 2015b. Strategy for malaria elimination in the greater mekong subregion. https:\/\/www.who.int\/publications\/i\/item\/9789290617181 [Accessed May 21, 2015]."},{"key":"bib163","type":"web-resource","article-title":"Minutes of the evidence review group meeting on the emergence and spread of multidrugresistant Plasmodium falciparum lineages in the greater mekong subregion","author":"World Health Organization","year":"2016","unstructured":"World Health Organization. 2016. Minutes of the evidence review group meeting on the emergence and spread of multidrugresistant Plasmodium falciparum lineages in the greater mekong subregion. https:\/\/www.who.int\/publications\/m\/item\/minutes-of-the-evidence-review-group-meeting-on-the-emergence-and-spread-of-multidrug-resistant-plasmodium-falciparum-lineages-in-the-greater-mekong-subregion [Accessed December 29, 2016]."},{"key":"bib164","type":"web-resource","article-title":"World Malaria Report","author":"World Health Organization","year":"2021","unstructured":"World Health Organization. 2021. World Malaria Report. https:\/\/www.who.int\/publications\/i\/item\/9789240040496 [Accessed December 6, 2021]."},{"key":"bib165","type":"web-resource","article-title":"WHO guidelines for malaria","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. 2022a. WHO guidelines for malaria. https:\/\/www.who.int\/news\/item\/18-11-2022-tackling-emerging-antimalarial-drug-resistance-in-africa [Accessed November 18, 2022]."},{"key":"bib166","type":"web-resource","article-title":"WHO guidelines for malaria","author":"World Health Organization","year":"2022","unstructured":"World Health Organization. 2022b. WHO guidelines for malaria. https:\/\/www.who.int\/publications\/i\/item\/guidelines-for-malaria [Accessed June 3, 2022]."},{"key":"bib167","type":"web-resource","article-title":"World malaria report","author":"World Health Organization","year":"2023","unstructured":"World Health Organization. 2023. World malaria report. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2023 [Accessed November 30, 2023]."},{"key":"bib168","type":"web-resource","article-title":"WHO malaria threats map.world health organisation","author":"World Health Organization, Global Malaria Programme","year":"2024","unstructured":"World Health Organization, Global Malaria Programme. 2024. WHO malaria threats map.world health organisation. https:\/\/www.who.int\/publications\/i\/item\/9789240090149 [Accessed April 23, 2024]."},{"key":"bib169","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-018-1207-3","type":"journal-article","article-title":"Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments\u2014a WWARN individual patient data meta-analysis","volume":"17","author":"WWARN K13 Genotype-Phenotype Study Group","year":"2019","journal-title":"BMC Medicine"},{"key":"bib170","doi-asserted-by":"publisher","first-page":"2917","DOI":"10.1016\/j.celrep.2019.10.095","type":"journal-article","article-title":"Decreased K13 abundance reduces Hemoglobin catabolism and proteotoxic stress, underpinning artemisinin resistance","volume":"29","author":"Yang","year":"2019","journal-title":"Cell Reports"},{"key":"bib171","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/infdis\/jiy637","type":"journal-article","article-title":"Comparative efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the treatment of uncomplicated malaria in ugandan children","volume":"219","author":"Yeka","year":"2019","journal-title":"The Journal of Infectious Diseases"},{"key":"bib172","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4269\/ajtmh.2004.71.179","type":"journal-article","article-title":"Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices","volume":"71","author":"Yeung","year":"2004","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"bib173","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1038\/s41591-023-02551-w","type":"journal-article","article-title":"Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda","volume":"29","author":"Zupko","year":"2023","journal-title":"Nature Medicine"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/105544\/elife-105544-v1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/105544\/elife-105544-v1.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/105544","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:21:21Z","timestamp":1787563281000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/105544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":173,"alternative-id":["10.7554\/eLife.105544"],"URL":"https:\/\/doi.org\/10.7554\/elife.105544","archive":["CLOCKSS"],"relation":{},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e105544"}}